“…These findings have led to overwhelming evidence of metabolic deficiencies in AD. Beyond reductions in brain glucose metabolism, mitochondrial dysfunction is observed not only within the brain but also systemically (Parker, 1991 ; Kish et al, 1992 ; Cardoso et al, 2004a , b ; Morris et al, 2014b ; Fisar et al, 2016 ; Guo et al, 2017 ; Swerdlow, 2018 ; Baloyannis, 2019 ; Chakravorty et al, 2019 ). More recent genome wide association studies (GWAS) identified risk-associated single nucleotide polymorphisms (SNPs) in genes which function in mitochondrial and metabolic pathways (Lakatos et al, 2010 ; Swerdlow et al, 2020 ; Harwood et al, 2021 ; Wightman et al, 2021 ).…”